20 June 2013
Keywords: gsk, acts, against, generic, marketers, zantac, israel
Article | 16 February 2004
Through its Israeli subsidiary, GlaxoSmithKline has petitioned the Tel Aviv District Court for a permanent injunction against local generic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2004
19 June 2013
© 2013 thepharmaletter.com